Promis Neurosciences Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Promis Neurosciences Inc with three other
miscellaneous service companies in North America:
Arch Biopartners Inc
sales of 37,641.00 Canadian Dollars [US$28,237.90 ]
Nexvet Biopharma plc
of the United States
of which 100%
was Clinical Stage Biopharmaceuticals), and
based in the United States
Sales fell dramatically in 2015:
Promis Neurosciences Inc reported sales of C$19,935.00 (US$14.96 thousand)
December of 2015.
decrease of 94.2%
versus 2014, when the company's sales were C$343,709.81 .